University of Michigan School of Nursing, Center for Improving Patient and Population Health, Ann Arbor, MI.
University of Michigan College of Pharmacy, Ann Arbor, MI.
JCO Oncol Pract. 2021 Oct;17(10):e1551-e1558. doi: 10.1200/OP.20.00816. Epub 2021 Feb 12.
Drug therapy for cancer is a high-risk, high-volume clinical intervention that requires interprofessional teams. Given the complexity of anticancer drug therapy and safety concerns, an interdisciplinary team developed a novel training program for oncology registered nurses and pharmacists to improve cancer drug safety.
Participants completed preworkshop learning assessments and received access to web-based modules on six topics: hazardous drug handling, drug extravasation, hypersensitivity reaction management, sepsis recognition, immune checkpoint inhibitor toxicities, and oral oncolytic adherence. In a 7-hour workshop, participants applied module content in interactive exercises and high-fidelity simulations. Preworkshop and postworkshop questionnaires assessed changes in knowledge and confidence in each topic. Program satisfaction and changes to clinical practice or policies were assessed 3 months after the workshop.
Two hundred ninety-two nurses and 82 pharmacists applied to participate, and 103 (35%) and 44 (54%) have participated, respectively. Long-term follow-up data were available on 133 (90%) participants. Change scores in confidence to meet program objectives increased between pre- and postworkshop (range of increase 0.6-0.8, < .01). Knowledge scores increased significantly between pre- and postworkshop (average improvement of 3.2 points, < .01). Overall program satisfaction was high (mean 5.0, standard deviation [0.2] on a five-point scale). Seventy-seven (60%) reported that they had made at least one clinical practice or institutional policy change at 3 months.
An interprofessional education program with online modules, in-person interactive sessions, and simulation activities is a promising strategy to deliver cancer drug safety content to practicing oncology clinicians.
癌症的药物治疗是一种高风险、大容量的临床干预措施，需要跨专业团队进行。鉴于抗癌药物治疗的复杂性和安全性问题，一个跨学科团队为肿瘤注册护士和药剂师开发了一个新的培训计划，以提高癌症药物的安全性。
参与者完成了预研讨会学习评估，并获得了六个主题的在线模块访问权限：危险药物处理、药物外渗、过敏反应管理、脓毒症识别、免疫检查点抑制剂毒性和口服肿瘤药物依从性。在为期 7 小时的研讨会上，参与者将模块内容应用于互动练习和高保真模拟中。在预研讨会和研讨会后问卷调查中，评估了每个主题的知识和信心变化。在研讨会结束后 3 个月评估了对计划的满意度以及对临床实践或政策的改变。
292 名护士和 82 名药剂师申请参加，分别有 103 名（35%）和 44 名（54%）参加。有 133 名（90%）参与者提供了长期随访数据。在预研讨会和研讨会之间，对满足计划目标的信心变化评分增加（增加范围为 0.6-0.8， <.01）。知识评分在预研讨会和研讨会之间显著增加（平均提高 3.2 分， <.01）。总体计划满意度很高（平均 5.0，五分制，标准差 [0.2]）。77 名（60%）报告说，他们在 3 个月内至少进行了一项临床实践或机构政策的改变。
在线模块、现场互动会议和模拟活动相结合的跨专业教育计划是向执业肿瘤临床医生提供癌症药物安全内容的有前途的策略。
